NCT02133183 2024-04-04Sapanisertib Before and After Surgery in Treating Patients With Recurrent GlioblastomaNational Cancer Institute (NCI)Phase 1 Terminated40 enrolled
NCT02987959 2022-10-14Study of TAK-228 (MLN0128) in Soft Tissue SarcomasFox Chase Cancer CenterPhase 2 Terminated6 enrolled 10 charts
NCT02601209 2022-08-23Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic SarcomaNational Cancer Institute (NCI)Phase 1/2 Terminated151 enrolled 22 charts